H

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692

Watchlist Manager
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Watchlist
Price: 17.24 HKD 0.7% Market Closed
Market Cap: 102.3B HKD
Have any thoughts about
Hansoh Pharmaceutical Group Company Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

14.1
Current
19
Median
13.7
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
14.1
=
Enterprise Value
77.1B HKD
/
EBITDA
5.1B CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
15.5
2-Years Forward
EV/EBITDA
16.6
3-Years Forward
EV/EBITDA
14.5

See Also

Discover More